Altimmune is simultaneously studying this drug for obesity, MASH, and soon alcohol related liver disease
The surge in popularity is also driven by the conflation of highly successful, legitimate therapeutic classeslike GLP-1 agonistswith entirely unrelated, unproven compounds
However, the trial did not demonstrate significant improvement in fibrosis
Li, Y., Zheng, X., Tang, L., Xu, W
PlexusDx's approach eliminates flat per-compound pricing tiers, meaning patients pay flat monthly rates regardless of how their dose escalates over timeprices remain consistent whether starting at low microdoses or advancing to therapeutic doses